Pulmonary interstitial tissue

Pulmonary interstitial tissue, also known as the lung interstitium, is a contiguous anatomical compartment located between the alveolar epithelial basement membrane and the capillary endothelial basement membrane (StatPearls, 2023). It provides the essential structural framework for the lungs and contains the extracellular matrix (ECM), fibroblasts, and immune cells necessary for maintaining lung mechanics and fluid homeostasis (NIH, 2022). In pathological conditions such as Idiopathic Pulmonary Fibrosis (IPF) or Interstitial Lung Disease (ILD), this tissue becomes the site of excessive collagen deposition and inflammation, which severely impairs gas exchange (Mayo Clinic, 2023). While drugs like Nintedanib and Pirfenidone are used to treat these conditions, they act on specific molecular targets like tyrosine kinase receptors or TGF-beta pathways within the tissue, rather than the tissue itself (PubMed, 2021). Therefore, while clinically significant, the pulmonary interstitial tissue is an anatomical region and not a single therapeutic target molecule. Its health is critical for respiratory function, as any thickening or scarring of this space increases the work of breathing and reduces oxygen diffusion (Wikipedia, 2024). Monitoring this tissue typically involves imaging and physiological testing rather than molecular assays of the tissue as a whole (StatPearls, 2023).

Other names

Lung interstitiumPulmonary interstitiumParenchymal interstitium

Not applicable; this is an anatomical tissue compartment rather than a specific molecular target.